Cutaneous Apocrine Adenocarcinoma of the Groin With Extramammary Paget Disease: Response to Dual HER2 Blockade With Trastuzumab and Pertuzumab

Actas Dermosifiliogr. 2022 Nov-Dec;113(10):973-975. doi: 10.1016/j.ad.2021.04.010. Epub 2021 Nov 11.

[Article in English, Spanish]

Authors

J Sola-Ortigosa¹, C Muñoz-Santos², M Hernández-Bronchud³, A Guilabert-Vidal²

Affiliations

¹ Department of Dermatology, Fundació Privada Hospital Asil de Granollers, Barcelona, España. Electronic address: quimsola@yahoo.com.
² Department of Dermatology, Fundació Privada Hospital Asil de Granollers, Barcelona, España.
³ GenesisCare Corachan Clinic, Barcelona, España.

PMID: 36460361
DOI: 10.1016/j.ad.2021.04.010

No abstract available

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Groin
Humans
Paget Disease, Extramammary* / drug therapy
Sweat Gland Neoplasms* / drug therapy
Trastuzumab / therapeutic use

Substances

Trastuzumab
pertuzumab
Antibodies, Monoclonal, Humanized